Name
Naerusuine OÜ
Registry code
14918434
VAT number
EE102234897
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
7 502 283 €
-23 368 €
-0%
2 300 €
(estimate is approximate)
-13 227 €
26
Submitted
No tax arrears
177%
-2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: MOONIKA MARKOV 28.12.1969 (54) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
| TRINITI Corporate Services OÜ 14284413 | - | - | - | Founder |
| 2020 14.06.2021 | 2021 29.06.2022 | 2022 29.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 4 388 430 € | 6 359 460 € | 6 916 697 € | 7 502 283 € |
| Net profit (loss) for the period | 11 940 € | 931 € | -5 230 € | -23 368 € |
| Profit Margin | 0% | 0% | -0% | -0% |
| Current Assets | 980 059 € | 983 979 € | 1 185 388 € | 1 214 446 € |
| Fixed Assets | - | - | - | - |
| Total Assets | 980 059 € | 983 979 € | 1 185 388 € | 1 214 446 € |
| Current Liabilities | 965 619 € | 968 608 € | 1 175 247 € | 1 227 673 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 14 440 € | 15 371 € | 10 141 € | -13 227 € |
| Employees | 24 | 23 | 26 | 26 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 2 087 311.4 € | 141 980.92 € | 102 185.19 € | 30 |
| 2023 Q4 | 2 097 561.88 € | 111 976.42 € | 89 249.4 € | 32 |
| 2023 Q3 | 1 819 107.14 € | 112 688.72 € | 95 122.25 € | 31 |
| 2023 Q2 | 1 985 751.78 € | 122 348.34 € | 96 218.84 € | 32 |
| 2023 Q1 | 1 941 745.79 € | 125 022.44 € | 96 343.31 € | 34 |
| 2022 Q4 | 1 850 884.56 € | 96 073.13 € | 82 087.55 € | 34 |
| 2022 Q3 | 1 649 551.94 € | 105 145.19 € | 90 925.83 € | 35 |
| 2022 Q2 | 1 825 223.63 € | 95 944.27 € | 80 317.91 € | 35 |
| 2022 Q1 | 1 753 116.9 € | 106 211.59 € | 81 681.63 € | 32 |
| 2021 Q4 | 1 886 920.64 € | 93 750.59 € | 67 941.61 € | 31 |
| 2021 Q3 | 1 506 155.11 € | 79 499.97 € | 71 142.4 € | 29 |
| 2021 Q2 | 1 612 553.22 € | 71 227.95 € | 64 365.1 € | 27 |
| 2021 Q1 | 1 488 531.73 € | 77 848.59 € | 63 104.47 € | 27 |
| 2020 Q4 | 1 674 398.84 € | 81 318.55 € | 66 425.08 € | 28 |
| 2020 Q3 | 1 486 685.09 € | 91 930.21 € | 73 949.55 € | 29 |
| 2020 Q2 | 966 013.48 € | 38 615.92 € | 26 040.64 € | 31 |
| 2020 Q1 | - | - | - | 33 |
